The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114190955 11419095 5 F 2014 20160905 20150826 20160906 EXP BR-ROCHE-1519472 ROCHE 0.00 F Y 65.00000 KG 20160906 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114190955 11419095 1 PS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) ON 26/MAY/2015, RECEIVED ONOTHER DOSE?MOSR RECENT DOSE ON 15/JAN/2016 U 103705 SOLUTION FOR INFUSION
114190955 11419095 2 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) LAST DOSE RECEIVED ON 26-MAY-2015 U 103705 SOLUTION FOR INFUSION
114190955 11419095 3 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) MOST RECENT DOSE U 103705 SOLUTION FOR INFUSION
114190955 11419095 4 SS AVALOX MOXIFLOXACIN HYDROCHLORIDE 1 Unknown U 0
114190955 11419095 5 SS TRAMAL TRAMADOL 1 Unknown U 0
114190955 11419095 6 C LIPITOR ATORVASTATIN CALCIUM 1 0
114190955 11419095 7 C PURAN LEVOTHYROXINE SODIUM 1 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 100 MG QD
114190955 11419095 8 C ARAVA LEFLUNOMIDE 1 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 30 MG QD
114190955 11419095 9 C TORLOS 2 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 50 MG QD
114190955 11419095 10 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 QD
114190955 11419095 11 C OMEGA 3 OMEGA-3 FATTY ACIDS 1 0
114190955 11419095 12 C NPH INSULIN INSULIN BEEF 1 Unknown 0 60 IU QD
114190955 11419095 13 C INSULIN INSULIN NOS 1 Unknown 0 20 IU QD
114190955 11419095 14 C SIMVASTATIN. SIMVASTATIN 1 0
114190955 11419095 15 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 20 MG
114190955 11419095 16 C ATORVASTATIN ATORVASTATIN 1 Unknown CAPSULE OR TABLET, NOT SPECIFIED 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114190955 11419095 1 Rheumatoid arthritis
114190955 11419095 4 Product used for unknown indication
114190955 11419095 5 Product used for unknown indication
114190955 11419095 7 Hypothyroidism
114190955 11419095 8 Rheumatoid arthritis
114190955 11419095 9 Blood pressure abnormal
114190955 11419095 15 Gastric disorder

Outcome of event

Event ID CASEID OUTC COD
114190955 11419095 HO
114190955 11419095 OT
114190955 11419095 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
114190955 11419095 Abasia
114190955 11419095 Arthralgia
114190955 11419095 Arthropathy
114190955 11419095 Asthma
114190955 11419095 Bacterial infection
114190955 11419095 Blood triglycerides abnormal
114190955 11419095 Cataract
114190955 11419095 Drug hypersensitivity
114190955 11419095 Pain
114190955 11419095 Speech disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114190955 11419095 1 20110425 20160101 0
114190955 11419095 2 20150501 0
114190955 11419095 3 20160115 0